Tokyo, Japan and London, UK, 13 May 2020 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2020. The full report can be accessed by clicking here.
Operational Highlights for Q1 2020
Financial Highlights for the Three-month Period ended 31 March 2020
* Convenience conversion to US$ at the following rates: 2020: 1US$ =108.907 JPY; 2019: 1US$ =110.226 JPY
 Non-IFRS measure
Shinichi Tamura, Chairman, President and CEO of Sosei Heptares, commented: “Our operating environment has changed dramatically in recent months as a result of the SARS-CoV-2 pandemic. I am very pleased to report that the company has responded extremely well to these changes by rapidly implementing practises to keep our staff, and other parties with whom we interact, safe and prevent any further spread of the virus; this is our main priority. The measures we have put in place have also ensured a high level of business continuity and enabled us to work on revenue-generating collaborations and other areas of key importance to our business. I am impressed with and extremely grateful to our staff for the level of dedication and commitment they have shown, which has allowed them to deliver outstanding results and scientific achievements in these unprecedented circumstances.”
Abbreviations used: GPCR – G protein-coupled receptors
– ENDS –